Short Interest in iHuman Inc. Sponsored ADR (NYSE:IH) Increases By 101.8%

iHuman Inc. Sponsored ADR (NYSE:IH) saw a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 456 shares, an increase of 101.8% from the February 12th total of 226 shares. Based on an average daily volume of 12,096 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 12,096 shares, the short-interest ratio is presently 0.0 days.

Hedge Funds Weigh In On iHuman

A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC purchased a new position in shares of iHuman Inc. Sponsored ADR (NYSE:IH) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,067 shares of the company’s stock, valued at approximately $32,000. 4.92% of the stock is currently owned by institutional investors and hedge funds.

iHuman Trading Down 4.0%

Shares of NYSE IH traded down $0.08 during midday trading on Friday, hitting $1.82. The company’s stock had a trading volume of 7,142 shares, compared to its average volume of 8,063. The firm has a market capitalization of $93.21 million, a price-to-earnings ratio of 6.51 and a beta of 0.05. The stock has a fifty day moving average price of $1.88 and a 200 day moving average price of $2.40. iHuman has a one year low of $1.67 and a one year high of $3.60.

iHuman (NYSE:IH) last issued its earnings results on Monday, December 29th. The company reported $0.06 EPS for the quarter. iHuman had a return on equity of 11.05% and a net margin of 12.55%.The business had revenue of $28.90 million during the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut iHuman from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

About iHuman

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.